Sex differences in nevirapine rash

SJ Bersoff-Matcha, WC Miller, JA Aberg… - Clinical infectious …, 2001 - academic.oup.com
Nevirapine is a nonnucleoside reverse transcriptase inhibitor (NNRTI) that has the most
common treatment limiting side effect of rash. Severe rash has been observed in 3% of patients …

Fournier gangrene associated with sodium–glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases

SJ Bersoff-Matcha, C Chamberlain, C Cao… - Annals of Internal …, 2019 - acpjournals.org
Background: Use of sodium–glucose cotransporter-2 (SGLT2) inhibitors has been associated
with Fournier gangrene (FG), a rare urologic emergency characterized by necrotizing …

Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the US Food and Drug …

SJ Bersoff-Matcha, K Cao, M Jason, A Ajao… - Annals of internal …, 2017 - acpjournals.org
Background: Direct-acting antiviral agents (DAAs) are used increasingly to treat hepatitis C
virus (HCV) infection. Reports were published recently on hepatitis B virus (HBV) reactivation …

Disseminated gonococcal infections in patients receiving eculizumab: a case series

…, SC Jones, SJ Bersoff-Matcha - Clinical Infectious …, 2019 - academic.oup.com
Background Gonorrhea is the second most commonly reported notifiable condition in the
United States. Infrequently, Neisseria gonorrhoeae can cause disseminated gonococcal …

Primary pulmonary botryomycosis: case report and review

SJ Bersoff-Matcha, CC Roper, H Liapis… - Clinical infectious …, 1998 - academic.oup.com
Botryomycosis is an uncommon bacterial disease characterized by the microscopic formation
of eosinophilic granules that resemble those of infection by Actinomyces species. The …

Unusual Neisseria species as a cause of infection in patients taking eculizumab

…, L McCulley, SC Jones, SJ Bersoff-Matcha - Journal of Infection, 2019 - Elsevier
Background Non-meningococcal, non-gonococcal Neisseria spp. are typically commensal
and rarely cause invasive disease. Eculizumab is a terminal complement inhibitor that …

[HTML][HTML] Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women

…, S Dhakal, C Barranta, H Golding, SJ Bersoff-Matcha… - medRxiv, 2023 - ncbi.nlm.nih.gov
… Golding, PhD, Critical revision of the manuscript for important intellectual content, 5 Susan
J. Bersoff-Matcha, MD, Critical revision of the manuscript for important intellectual content, 6 …

[HTML][HTML] Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease

…, L McCulley, SC Jones, SJ Bersoff-Matcha - The Journal of …, 2020 - ncbi.nlm.nih.gov
We recently published a case series of typically commensal Neisseria spp. disease among
eculizumab recipients [1]. Eculizumab is a terminal complement inhibitor indicated for …

Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1

SJ Bersoff-Matcha, MM Horgan… - The Journal of …, 1998 - academic.oup.com
Recent evidence suggests that sexually transmitted diseases (STDs) enhance the transmission
of human immunodeficiency virus (HIV) type 1. In 143 HIV-infected women enrolled in a …

Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy

…, S Dhakal, C Barranta, H Golding, SJ Bersoff-Matcha… - Msphere, 2024 - Am Soc Microbiol
In this retrospective observational cohort study, we analyzed remnant clinical samples from
non-pregnant and pregnant individuals with confirmed severe acute respiratory syndrome …